Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.38 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12445587 | 0.86 | TSHR (0.39) | ALDH1A1TDP1 | |
| SCHEMBL2922692 | 0.84 | — | — | |
| SCHEMBL23776129 | 0.82 | ACE2 (0.41) | ALDH1A1TDP1ACE2OPRM1LMNA | |
| SCHEMBL3616888 | 0.78 | ALDH1A1 (0.48) | ALDH1A1TDP1ACE2OPRM1LMNA | |
| SCHEMBL27558484 | 0.78 | ACE2 (0.52) | ALDH1A1TDP1ACE2OPRM1LMNA | |
| SCHEMBL18286447 | 0.77 | ACE2 (0.43) | ALDH1A1TDP1ACE2OPRM1LMNA | |
| SCHEMBL18256105 | 0.77 | ACE2 (0.43) | ALDH1A1TDP1ACE2OPRM1LMNA | |
| SCHEMBL25727439 | 0.77 | ALDH1A1 (0.48) | ALDH1A1TDP1ACE2OPRM1LMNA | |
| SCHEMBL17469945 | 0.77 | ACE2 (0.43) | ALDH1A1TDP1ACE2OPRM1LMNA | |
| SCHEMBL18085385 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200230133-A1 | Discrete PEG Constructs | EqIP, LLC (US) | 2020-07-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200230133-A1 | Discrete PEG Constructs | MUC1, EGFR, LNPEP | ALDH1A1 3743/4885TDP1 3865/4885ACE2 2849/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.